Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Recommendation of "Buy" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) Director Jan Skvarka sold 5,000 shares of the stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $25.05, for a total transaction of $125,250.00. Following the transaction, the director now directly owns 47,970 shares of the company’s […]
Toronto, Ontario (Newsfile Corp. - September 30, 2022) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Pieter Cullis, Co-Founder of Acuitas Therapeutics, as the recipient of the 2022 Bloom